Current Therapy of the Patients with MDS: Walking towards Personalized Therapy

Myelodysplastic syndromes (MDS) are characterized by ineffective hematopoiesis, dysplasia and peripheral cytopenias. Nowadays, MDS therapy is selected based on risk. The goals of therapy are different in low-risk and high-risk patients. In low-risk MDS, the goal is to decrease transfusion needs and...

Descripción completa

Detalles Bibliográficos
Autores principales: Palacios-Berraquero, Maria Luisa, Alfonso-Piérola, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153316/
https://www.ncbi.nlm.nih.gov/pubmed/34068316
http://dx.doi.org/10.3390/jcm10102107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153316/
https://www.ncbi.nlm.nih.gov/pubmed/34068316
http://dx.doi.org/10.3390/jcm10102107

Ejemplares similares